<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a 47-year-old woman with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> with genital <z:mp ids='MP_0001914'>bleeding</z:mp> who developed <z:hpo ids='HP_0011009'>acute</z:hpo> severe <z:hpo ids='HP_0012115'>hepatitis</z:hpo> after the administration of <z:chebi fb="1" ids="4315">danazol</z:chebi> while she was receiving cyclosporin </plain></SENT>
<SENT sid="1" pm="."><plain>She had been diagnosed with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> 1 year previously and, while hospitalized, had received <z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="2" ids="8378">prednisolone</z:chebi> pulse therapy, which was not successful </plain></SENT>
<SENT sid="2" pm="."><plain>She was then referred to our hospital </plain></SENT>
<SENT sid="3" pm="."><plain>She was treated with antithymocyte globulin, cyclosporin, granulocyte colony-stimulating factor, and <z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="2" ids="8378">prednisolone</z:chebi>; a good response was achieved after 3 months of this therapy </plain></SENT>
<SENT sid="4" pm="."><plain>Subsequently, oral administration of cyclosporin was continued, but she was readmitted to our hospital when <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> gradually developed and the genital <z:mp ids='MP_0001914'>bleeding</z:mp> recurred </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="1" ids="4315">Danazol</z:chebi> was administered for <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> and <z:e sem="disease" ids="C0014175" disease_type="Disease or Syndrome" abbrv="">endometriosis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Four days after the first administration of <z:chebi fb="1" ids="4315">danazol</z:chebi>, epigastric pain occurred, and the <z:chebi fb="1" ids="4315">danazol</z:chebi> was stopped </plain></SENT>
<SENT sid="7" pm="."><plain>Eighteen days after the first <z:chebi fb="1" ids="4315">danazol</z:chebi> administration, very severe hepatic injury occurred abruptly </plain></SENT>
<SENT sid="8" pm="."><plain>The patient died of <z:hpo ids='HP_0001399'>hepatic failure</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Postmortem examination revealed centrilobular massive <z:mp ids='MP_0001651'>necrosis</z:mp> of the liver </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="1" ids="4315">Danazol</z:chebi> was implicated as the agent responsible for causing the <z:hpo ids='HP_0001399'>hepatic failure</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Drug interactions between <z:chebi fb="1" ids="4315">danazol</z:chebi> and cyclosporin may cause adverse effects </plain></SENT>
</text></document>